The Efficacy and Safety of Intra-oral Topical Ketoprofen for the Treatment of Acute Migraine
Launched by BEHAR, CAREN, M.D. · Oct 25, 2010
Trial Information
Current as of April 29, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Established diagnosis of Migraine as per IHS with aura
- • Established diagnosis of Migraine as per IHS without aura
- • At least 2 migraines per month
- • At least 18 years of age
- Exclusion Criteria:
- • Pregnancy or Lactation
- • Other Headache Conditions including basilar, hemiplegic, or ophthalmoplegic migraines
- • Chronic Daily Headache
- • Allergy or Sensitivity to NSAIDs
- • Other Severe Medical Conditions including GI bleeding, blood dyscrasias, thrombocytopenia
About Behar, Caren, M.D.
Dr. Caren Behar, M.D., is a distinguished clinical trial sponsor known for her commitment to advancing medical research and improving patient outcomes. With extensive experience in clinical practice and trial management, Dr. Behar leads innovative studies that focus on developing effective therapies across various medical disciplines. Her dedication to rigorous scientific standards and ethical conduct ensures the integrity of research processes while fostering collaboration among multidisciplinary teams. Under her guidance, clinical trials aim to address unmet medical needs and contribute valuable insights to the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Valhalla, New York, United States
Patients applied
Trial Officials
Caren Behar, MD
Principal Investigator
New York Medical College
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials